Study of the effect of tofogliflozin on glucose and lipid metabolism abnormality after the test meal loading

Trial Profile

Study of the effect of tofogliflozin on glucose and lipid metabolism abnormality after the test meal loading

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Tofogliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Jun 2017 Last checked against the University Hospital Medical Information Network - Japan record.
    • 31 May 2017 Status changed from active, no longer recruiting to completed.
    • 14 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top